B cell lymphoma 2/Bcl2
Rb, 0.1 ml Conc.
Technische Daten
Reaktivität AK: | Human, Mouse, Rat, others not tested. | Format AK: | Concentrate | Klon: | Polyclonal | Spezies: | Rabbit | Ig Unterklasse: | IgG | Immunogen: | Synthetic peptide of human Bcl2 | Anwendung AK: | IHC(p*) *reported as working on paraffin,IHC(f),WB,ELISA | Fixierung: | 1) NOTOXhisto 2) Formalin | Zelluläre Lokalisation: | Cytoplasmic | Kontrolle: | Tonsil | Lagerung AK: | Aliquot and store at - 20 °C. Do not use after expiration date indicated on the vial. | Synonyme: | TGF Beta 1, TGF _1, TGF-_1,TGF_2, TGF_3, CED, Diaphyseal dysplasia 1 progressive, DPD 1, DPD1, TGF beta 1, TGF beta, TGF beta1, TGF beta2, TGF beta3, TGFB 1, TGFB, TGFB1, TGFB2, TGFB3, Transforming growth factor, Transforming growth factor beta 1, Transforming growth factor beta 2, Transforming growth factor beta 3, Transforming Growth Factor beta. | Verfügbar in folgenden Ländern: | world wide | Status: | RUO |
Beschreibung
This antibody recognizes the anti-apoptotic protein BCL2, which is useful in distinguishing between neoplastic and reactive follicular lymphoma (BCL2-negative). It indcates cancers of breast, prostate, ovary, endometrium and colon.
|